Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lonsky, V.
Right arrow Articles by Kubícek, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lonsky, V.
Right arrow Articles by Kubícek, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Serum oxacillin and cephazolin levels during cardiopulmonary bypass

Vladimir Lonsky

Cardiosurgical Clinic, Faculty Hospital, Charles' University

Jirí Mandák

Cardiosurgical Clinic, Faculty Hospital, Charles' University

Vera Lonská

Department of Microbiology, Faculty Hospital, Charles' University

Vladimir Rozsival

Cardiosurgical Clinic, Faculty Hospital, Charles' University, Hradec Králové, Czechoslovakia

Dana Marková

Cardiosurgical Clinic, Faculty Hospital, Charles' University, Hradec Králové, Czechoslovakia

Jaroslav Kubícek

Cardiosurgical Clinic, Faculty Hospital, Charles' University, Hradec Králové, Czechoslovakia

This study was carried out to assess the adequacy of the dosing regimen for the oxacillin and cephazolin, employed as prophylactic antibiotics for patients undergoing open-heart surgery. The serum levels of both antibiotics were measured during cardiopulmonary bypass.

The highest serum levels of both antibiotics were found 30 minutes after their administration (> 24mg/l). During perfusion the serum levels were not stable and decreased to < 2mg/l after 180 minutes in the oxacillin group and after 150 minutes in the cephazolin group. These levels are below the minimum inhibitory concentrations for anti-staphylococcal activity. A second dose of antibiotic at the end of cardiopulmonary bypass should be administered in order to maintain an anti-staphylococcal concentration of antibiotics in the newly formed blood clots. Earlier administration of both antibiotics is recommended in cases where perfusion time exceeds the above mentioned intervals.

Perfusion, Vol. 7, No. 2, 115-118 (1992)
DOI: 10.1177/026765919200700206


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?